Some Hydroids (Cnidaria, Hydrozoa) from the Great Australian Bight in the collection of the South Australian Museum.

This report adds to knowledge of the shelf hydroid fauna of the Great Australian Bight. Hydroids were collected by the South Australian Museum and Department of Primary Industries of South Australia (PIRSA). Well known species are annotated, poorly known species are redescribed and four new species are described.

A new species of Gonionemus (Hydrozoa: Limnomedusae) from southern Australia.

A new species of a crawling limnomedusa belonging to the genus Gonionemus (Hydrozoa: Limnomedusae: Olindiidae) was collected from the brown alga Cystophora monilifera in an intertidal rock pool in Western Port, Victoria, Australia. The new species is described and compared with the three known species of Gonionemus. The mitochondrial DNA barcode markers cytochrome oxidase I and 16S rRNA were sequenced and compared to sequences from other olindiid species.

Two bathyal hydroids (Hydrozoa: Leptothecata) from the Southwest Indian Ocean.

Two species of hydroids were recovered from a mooring rope and experimentally deployed whale bone attached to an underwater transponder buoy at a depth of 732 m on the Coral Seamount on the Southwest Indian Ocean Ridge (41° 22.31'S, 54° 57'E) in the Southern Indian Ocean. The material was collected approximately 1,500 km south south-east of Madagascar during Voyage JC066 of the British Royal Research Ship R.

An evaluation of the brain distribution of [(11)C]GSK1034702, a muscarinic-1 (M 1) positive allosteric modulator in the living human brain using positron emission tomography.

Background: The ability to quantify the capacity of a central nervous system (CNS) drug to cross the human blood-brain barrier (BBB) provides valuable information for de-risking drug development of new molecules. Here, we present a study, where a suitable positron emission tomography (PET) ligand was not available for the evaluation of a potent muscarinic acetylcholine receptor type-1 (M1) allosteric agonist (GSK1034702) in the primate and human brain. Hence, direct radiolabelling of the novel molecule was performed and PET measurements were obtained and combined with in vitro equilibrium dialysis assays to enable assessment of BBB transport and estimation of the free brain concentration of GSK1034702 in vivo.

Receptor occupancy and brain free fraction.

This study was designed to investigate whether brain unbound concentration (C(u,brain)) is a better predictor of dopamine D(2) receptor occupancy than total brain concentration, cerebrospinal fluid concentration (C(CSF)), or blood unbound concentration (C(u,blood)). The ex vivo D(2) receptor occupancy and concentration-time profiles in cerebrospinal fluid, blood, and brain of six marketed antipsychotic drugs were determined after oral administration in rats at a range of dose levels. The C(u,brain) was estimated from the product of total brain concentration and unbound fraction, which was determined using a brain homogenate method.